We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$131B
1-Year Est. Return
28.36%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$73.7B
AUM Growth
+$1.12B
(+1.5%)
Cap. Flow
-$2.18B
Cap. Flow
% of AUM
-2.96%
Top 10 Holdings %
Top 10 Hldgs %
9.5%
Holding
1,683
New
151
Increased
555
Reduced
775
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$212M |
| 2 |
Starbucks
SBUX
|
+$151M |
| 3 |
Kroger
KR
|
+$118M |
| 4 |
Western Midstream Partners
WES
|
+$101M |
| 5 |
Fortive
FTV
|
+$89.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEIC
FEI COMPANY
FEIC
|
+$191M |
| 2 |
CVS Health
CVS
|
+$140M |
| 3 |
Danaher
DHR
|
+$139M |
| 4 |
Wells Fargo
WFC
|
+$127M |
| 5 |
PayPal
PYPL
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 14.66% |
| 3 | Industrials | 13.2% |
| 4 | Healthcare | 12.87% |
| 5 | Energy | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Supernus Pharmaceuticals
SUPN
$2.79B
| $655K | ﹤0.01% |
26,500
+7,500
| +39% | +$170K |
|
1202
Jefferies Financial Group
JEF
$12.9B
| $651K | ﹤0.01% |
38,185
-6,219
| -14% | -$103K |
|
|
DCUD
1203
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $646K | ﹤0.01% |
+12,950
| New | +$660K |
|
1204
Carter's
CRI
$1.43B
| $645K | ﹤0.01% |
7,437
+62
| +0.8% | +$6.22K |
|
1205
Omega Flex
OFLX
$300M
| $636K | ﹤0.01% |
16,491
+2,626
| +19% | +$96.2K |
|
1206
MidCap Financial Investment
MFIC
$812M
| $633K | ﹤0.01% |
36,390
+267
| +0.7% | +$4.68K |
|
1207
Marathon Petroleum
MPC
$91.3B
| $633K | ﹤0.01% |
15,592
-985
| -6% | -$40K |
|
1208
State Street SPDR S&P Dividend ETF
SDY
$22.3B
| $631K | ﹤0.01% |
7,477
+314
| +4% | +$26.8K |
|
1209
United Natural Foods
UNFI
$3.12B
| $622K | ﹤0.01% |
+15,534
| New | +$713K |
|
1210
Pediatrix Medical
MD
$2.2B
| $621K | ﹤0.01% |
9,367
-173
| -2% | -$11.8K |
|
1211
TriplePoint Venture Growth BDC
TPVG
$184M
| $614K | ﹤0.01% |
57,940
-3,048
| -5% | -$34.1K |
|
|
CORE
1212
DELISTED
Core Mark Holding Co., Inc.
CORE
| $614K | ﹤0.01% |
17,141
+341
| +2% | +$14.7K |
|
|
TSRO
1213
DELISTED
TESARO, Inc.
TSRO
| $605K | ﹤0.01% |
6,040
+3,000
| +99% | +$280K |
|
|
FOMX
1214
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $602K | ﹤0.01% |
+65,000
| New | +$543K |
|
1215
Bruker
BRKR
$9.73B
| $600K | ﹤0.01% |
26,500
-5,300
| -17% | -$121K |
|
|
VTLE
1216
DELISTED
Vital Energy
VTLE
| $600K | ﹤0.01% |
+2,324
| New | +$530K |
|
1217
Liberty Broadband Class C
LBRDK
$4.65B
| $596K | ﹤0.01% |
8,335
-476
| -5% | -$31.8K |
|
1218
iShares Core S&P Total US Stock Market ETF
ITOT
$93.4B
| $594K | ﹤0.01% |
12,002
-2,130
| -15% | -$105K |
|
1219
Dolby
DLB
$4.96B
| $592K | ﹤0.01% |
10,910
+2,020
| +23% | +$101K |
|
1220
Manulife Financial
MFC
$73.6B
| $592K | ﹤0.01% |
41,976
+9,249
| +28% | +$126K |
|
|
CIT
1221
DELISTED
CIT Group Inc.
CIT
| $592K | ﹤0.01% |
16,303
-17,936
| -52% | -$626K |
|
1222
Cavco Industries
CVCO
$4.48B
| $586K | ﹤0.01% |
+5,916
| New | +$590K |
|
|
LNKD
1223
DELISTED
LinkedIn Corporation
LNKD
| $586K | ﹤0.01% |
3,065
-84,715
| -97% | -$16.2M |
|
1224
TransUnion
TRU
$16.2B
| $582K | ﹤0.01% |
+16,863
| New | +$565K |
|
1225
E.W. Scripps
SSP
$280M
| $579K | ﹤0.01% |
36,400
-1,600
| -4% | -$26.6K |
|
Similar funds
DAM
Neuberger Berman Group's Q3 2016 Portfolio in Review
As of Q3 2016, Neuberger Berman Group held 1,683 positions worth $73.7B, up 1.5% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
Neuberger Berman Group's Q3 2016 filing shows 151 new, 555 increased, 775 reduced and 101 closed positions. Its largest new stake was Fortive: 2,781,172 shares worth $89.3M. The largest sale was FEI COMPANY, an estimated $191M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
- Neuberger Berman Group's largest Q3 2016 buy was Fortive: 2,781,172 shares worth $89.3M.
- Neuberger Berman Group added most to Leidos in Q3 2016, an estimated $212M increase.
- Neuberger Berman Group's biggest Q3 2016 reduction was CVS Health, cutting an estimated $140M.
- Neuberger Berman Group fully exited FEI COMPANY in Q3 2016, selling an estimated $191M.
- Neuberger Berman Group's ten largest holdings make up 9.5% of its $73.7B portfolio in Q3 2016.
- Neuberger Berman Group opened 151 new positions and closed 101 in Q3 2016.
- Neuberger Berman Group's portfolio value rose 1.5% quarter-over-quarter to $73.7B.
Based on Neuberger Berman Group's 13F filing for Q3 2016, filed 2 Nov 2016.